サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1768562

体外診断薬（IVD）品質管理の世界市場

In Vitro Diagnostics (IVD) Quality Control

出版日
ページ情報
英文 275 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
体外診断薬（IVD）品質管理の世界市場
出版日: 2025年07月11日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 275 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

体外診断薬（IVD）品質管理の世界市場は2030年までに18億米ドルに達する

2024年に14億米ドルと推定される体外診断薬（IVD）品質管理の世界市場は、2024～2030年の分析期間においてCAGR 5.3%で成長し、2030年には18億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである臨床化学は、CAGR 6.1％を記録し、分析期間終了時には6億760万米ドルに達すると予測されます。免疫化学分野の成長率は、分析期間中CAGR 4.6％と推定されます。

米国市場は3億5,080万米ドルと推定、中国はCAGR8.7%で成長予測

米国の体外診断薬（IVD）品質管理市場は、2024年には3億5,080万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを8.7%として、2030年までに4億3,760万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.6%と4.1%と予測されています。欧州では、ドイツがCAGR 3.5%で成長すると予測されています。

世界の体外診断薬（IVD）品質管理市場- 主要動向と促進要因のまとめ

なぜ体外診断薬（IVD）品質管理が正確なヘルスケア診断に不可欠なのか？

体外診断薬（IVD）品質管理は、検査室で行われる診断テストの正確性、信頼性、一貫性を確保する上で極めて重要な役割を果たしています。体外診断用医薬品（IVD）検査は、病気の診断、健康状態のモニタリング、治療方針の決定に不可欠なツールです。これらの検査には、血液検査、分子診断、微生物学的検査が含まれ、様々な医療分野で使用されています。体外診断用医薬品（IVD）における品質管理（QC）対策は、検査結果の誤りや矛盾を検出するのに役立ち、そうでなければ誤った診断や治療につながる可能性があるため、極めて重要です。IVDにおけるQCには、診断機器の定期的な校正、検査手順のバリデーション、コントロールサンプルによる検査性能のモニタリングが含まれ、診断結果が信頼できるものであることを保証します。

技術の進歩はIVD品質管理市場をどのように形成しているか？

体外診断用医薬品の品質管理市場は、技術の進歩により大きな変革期を迎えています。検査室での自動化がますます進み、人為的ミスが減り、検査結果の精度が向上しています。多項目対照を含む高度な対照物質の開発により、複数のパラメータを同時にモニターする能力が向上し、包括的な品質チェックが保証されています。さらに、分子診断やポイントオブケア検査は急速に成長しており、これらの新しい技術の複雑さと特異性に対応できる、より洗練された品質管理プロセスの必要性につながっています。さらに、AI主導のデータ分析が体外診断用医薬品の品質管理システムに統合されつつあり、検査室が潜在的な問題を予測し、リアルタイムでプロセスを調整することを可能にし、診断の信頼性をさらに高めています。

市場セグメンテーションはIVD品質管理市場の成長をどのように規定するか？

製品タイプには、品質管理材料、データ管理ソフトウェア、機器が含まれ、品質管理材料は様々な診断検査に幅広く適用できるため、最大の市場シェアを占めています。IVD品質管理のアプリケーションには、臨床化学、免疫測定、血液学、分子診断学が含まれ、個別化医療や遺伝子検査が普及するにつれて分子診断学が最も急速に成長しています。エンドユーザーには病院、臨床検査室、学術・研究機関が含まれるが、臨床検査室は検査量が多く、一貫した信頼性の高い結果が極めて重要であることから、最大のセグメントとなっています。市場も世界的に拡大しており、北米と欧州が導入でリードしている一方、アジア太平洋地域はヘルスケア・インフラ投資の増加により急成長を遂げています。

IVD品質管理市場の成長を促進する要因とは？

IVD品質管理市場の成長は、正確な診断に対する需要の増加、慢性疾患や感染症の流行の増加、診断精度に対する厳しい規制要件など、いくつかの要因によってもたらされます。ヘルスケアシステムがより良い結果を提供しようと努力する中、正確な診断ツールの必要性は最も重要であり、検査施設は強固な品質管理対策への投資を余儀なくされています。また、がん、糖尿病、心血管疾患などの疾病の罹患率の増加も診断検査に対する需要の増加に寄与しており、IVDにおける品質管理の必要性を高めています。さらに、FDAや欧州医薬品庁（EMA）などの規制機関がより厳格なガイドラインを導入し、患者の安全性と検査の信頼性を確保するために厳格なQCの実施を義務付けており、市場の成長をさらに後押ししています。

セグメント

用途（臨床化学、免疫化学、分子診断、血液学、その他の用途）、最終用途（病院、臨床検査室、その他の最終用途）

調査対象企業の例

  • Abbott Laboratories
  • Becton, Dickinson And Company（BD）
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Eurotrol B.V.
  • F. Hoffmann-La Roche Ltd.
  • Fortress Diagnostics Limited
  • Helena Biosciences Europe
  • Maine Molecular Quality Controls, Inc.
  • Merck KGaA
  • Omega Diagnostics Group Plc
  • Ortho Clinical Diagnostics
  • Randox Laboratories Ltd.
  • Seracare Life Sciences Inc.
  • Sero As
  • Siemens Ag
  • Sun Diagnostics, LLC.
  • Technopath Clinical Diagnostics
  • Thermo Fisher Scientific Inc.
  • Zeptometrix Corporation

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP22020

Global In Vitro Diagnostics (IVD) Quality Control Market to Reach US$1.8 Billion by 2030

The global market for In Vitro Diagnostics (IVD) Quality Control estimated at US$1.4 Billion in the year 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Clinical Chemistry, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$607.6 Million by the end of the analysis period. Growth in the Immunochemistry segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$350.8 Million While China is Forecast to Grow at 8.7% CAGR

The In Vitro Diagnostics (IVD) Quality Control market in the U.S. is estimated at US$350.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$437.6 Million by the year 2030 trailing a CAGR of 8.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global In Vitro Diagnostics (IVD) Quality Control Market - Key Trends and Drivers Summarized

Why Is In Vitro Diagnostics (IVD) Quality Control Critical for Accurate Healthcare Diagnostics?

In Vitro Diagnostics (IVD) quality control plays a pivotal role in ensuring the accuracy, reliability, and consistency of diagnostic tests performed in laboratories. IVD tests are essential tools for diagnosing diseases, monitoring health conditions, and guiding treatment decisions. These tests include blood tests, molecular diagnostics, and microbiological assays, and they are used across various medical disciplines. Quality control (QC) measures in IVD are crucial because they help detect errors or inconsistencies in test results, which could otherwise lead to incorrect diagnoses or treatments. QC in IVD involves the regular calibration of diagnostic equipment, validation of test procedures, and monitoring of test performance through control samples, ensuring that the diagnostic outcomes are reliable and trustworthy.

How Are Technological Advancements Shaping the IVD Quality Control Market?

The IVD quality control market is undergoing significant transformation, thanks to advancements in technology. Automation in laboratories is increasingly being adopted, reducing human error and improving the accuracy of test results. The development of advanced control materials, including multi-analyte controls, has improved the ability to monitor multiple parameters simultaneously, ensuring comprehensive quality checks. Additionally, molecular diagnostics and point-of-care testing are growing rapidly, leading to the need for more sophisticated quality control processes that can handle the complexity and specificity of these newer technologies. Moreover, AI-driven data analysis is being integrated into IVD quality control systems, enabling laboratories to predict potential issues and adjust processes in real-time, further enhancing the reliability of diagnostics.

How Do Market Segments Define the Growth of the IVD Quality Control Market?

Product types include quality control materials, data management software, and instruments, with quality control materials holding the largest market share due to their wide applicability in various diagnostic tests. Applications of IVD quality control include clinical chemistry, immunoassay, hematology, and molecular diagnostics, with molecular diagnostics witnessing the fastest growth as personalized medicine and genetic testing gain traction. End-users include hospitals, clinical laboratories, and academic and research institutions, with clinical laboratories being the largest segment due to their high volume of testing and the critical need for consistent, reliable results. The market is also expanding globally, with North America and Europe leading in adoption, while the Asia-Pacific region is experiencing rapid growth due to increasing healthcare infrastructure investments.

What Factors Are Driving the Growth in the IVD Quality Control Market?

The growth in the IVD quality control market is driven by several factors, including the increasing demand for accurate diagnostics, the rising prevalence of chronic and infectious diseases, and stringent regulatory requirements for diagnostic accuracy. As healthcare systems strive to provide better outcomes, the need for precise diagnostic tools is paramount, pushing laboratories to invest in robust quality control measures. The increasing incidence of diseases such as cancer, diabetes, and cardiovascular conditions is also contributing to higher demand for diagnostic tests, thus driving the need for quality control in IVD. Furthermore, regulatory agencies such as the FDA and the European Medicines Agency (EMA) have implemented stricter guidelines, mandating rigorous QC practices to ensure patient safety and test reliability, further fueling market growth.

SCOPE OF STUDY:

The report analyzes the In Vitro Diagnostics (IVD) Quality Control market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology, Other Applications); End-Use (Hospitals, Clinical Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Abbott Laboratories
  • Becton, Dickinson And Company (BD)
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Eurotrol B.V.
  • F. Hoffmann -La Roche Ltd.
  • Fortress Diagnostics Limited
  • Helena Biosciences Europe
  • Maine Molecular Quality Controls, Inc.
  • Merck KGaA
  • Omega Diagnostics Group Plc
  • Ortho Clinical Diagnostics
  • Randox Laboratories Ltd.
  • Seracare Life Sciences Inc.
  • Sero As
  • Siemens Ag
  • Sun Diagnostics, LLC.
  • Technopath Clinical Diagnostics
  • Thermo Fisher Scientific Inc.
  • Zeptometrix Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • In Vitro Diagnostics (IVD) Quality Control - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Point-of-Care Testing Propels Demand for IVD Quality Control
    • Growing Incidence of Chronic Diseases Spurs Need for Reliable Diagnostics
    • Technological Innovations in Molecular Diagnostics Expands Market Potential
    • Automation and AI Integration Strengthens Business Case for IVD Quality Control
    • Heightened Focus on Personalized Medicine Propels Adoption of Precision Diagnostics
    • Rising Awareness of Preventive Healthcare Accelerates Demand for IVD Testing
    • Adoption of Companion Diagnostics Expands Addressable Market
    • Advancements in Multiplex Assays Generates Opportunities for Enhanced Accuracy
    • Stringent Quality Standards in Healthcare Fuel Investments in IVD Quality Control
    • Growth of Telemedicine Strengthens Demand for Remote Diagnostic Solutions
    • Focus on Reducing Diagnostic Errors Expands Adoption of Quality Control Measures
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Immunochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Immunochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Immunochemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Clinical Chemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World In Vitro Diagnostics (IVD) Quality Control Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION